Goldwater Institute Senior Policy Advisor Starlee Coleman appeared on C-SPAN’s Washington Week today to talk about the Right to Try, a law that protects terminally ill patients’ right to try investigational medicines that have not yet received full FDA approval.
Coleman explained that the law is a “completely patient-focused, bipartisan effort” with support from myriad organizations across the nation:
“One of the things that is so amazing about this issue is the types of people that come together to support it. In Texas, for example, when the state law was passing, the Texas AFL-CIO joined with the Catholic Bishops Conference and a number of other patient groups like the metastatic breast cancer community, ALS advocacy organizations, and others to come together to support this law.”
Today, Right to Try is law in 38 states, has passed the U.S. Senate unanimously, and is under consideration in the U.S. House.
If you’re interested in learning more about Right to Try or becoming an advocate, visit RightToTry.org.